CD38 and COVID-19: In a cohort of 43 COVID-19 patients and 25 healthy controls, circulating MAIT cells displayed reduced frequency and an activated phenotype in individuals with COVID-19, regardless of disease severity, as characterised by high expression of IL-17A, TNFα, CD38, CD69 and HLA-DR [88].